Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Miller Mary received 49,830 Acrivon Therapeutics, Inc. shares as an award (Form 4)

Traded May 18, 2026 · Filed May 20, 2026

On May 18, 2026, Miller Mary (Chief Legal Officer) received 49,830 Acrivon Therapeutics, Inc. shares as an award, leaving 82,767 shares. Filed May 20, 2026 (Form 4).

Awarded
49,830 shares
Holding after
82,767 shares
Trading plan
No
Role
Chief Legal Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 18, 2026Common StockAward49,83082,767Direct

Source

View original at SEC

Related